The PCR-based test can simultaneously detect for the Zika virus, all serotypes of the dengue virus, the chikungunya virus, the West Nile virus, and a host gene.
Phylogenetic patterns for more than 2,200 dengue viruses collected in Asia over almost 60 years suggest air travel hubs have contributed to the virus' spread in the region.
The group will study the potential risks and benefits of using CRISPR/Cas9 to develop gene drive systems for control and manipulation of mosquito populations.
The method uses graphene-coated silica particles fused to complementary RNA to register impedance changes in the presence of viruses.
The firms also plan to launch a multiplex test for multiple pathogens, including dengue.
Some voters in Florida are considering a ballot question about using genetically modified mosquitos to halt the spread of disease.
The kit is a qualitative nucleic acid assay designed to test for Zika, dengue, and chikungunya viruses simultaneously.
Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
The deal gives Bio-Rad licensing rights to a PCR-based platform and an assay that improves diagnostic sensitivity and efficacy across four dengue serotypes.
The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.